Fatima Bint Mubarak Centre Celebrates A Year Of Groundbreaking Cancer Care In The UAE

Cleveland Clinic Abu Dhabi, a key member of the M42 network, is celebrating a significant milestone with the Fatima bint Mubarak Centre reaching its first anniversary. This event marks a year since its inauguration by H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi. The centre, known for its advanced cancer care, has served as a beacon of hope and medical excellence for over 3,000 new cancer patients in the UAE and surrounding regions.

Throughout its first year, the Fatima bint Mubarak Centre has seen over 30,000 clinic visits, administered 6,000 radiation treatments, provided 6,500 chemotherapy infusions, and conducted 7,000 imaging studies. Drawing inspiration from Cleveland Clinic’s Taussig Cancer Centre in the US, it employs a multidisciplinary approach to cancer care. This comprehensive strategy encompasses everything from screening and diagnostic testing to advanced radiation treatments and precision cellular therapies.

Dr. Stephen Grobmyer, Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi, highlighted the centre's commitment to advancing cancer care in the region. He emphasized the collaborative efforts that have bolstered their multidisciplinary approach in combating cancer. Dr. Grobmyer also acknowledged the UAE leadership's vision and the central role of patients and their families in their mission.

The Fatima bint Mubarak Centre is renowned for its patient-first philosophy and multidisciplinary oncology team. Their diverse skill set and specialized knowledge ensure a comprehensive treatment plan tailored to each patient's history and condition. This dedication to excellence has earned them a three-year accreditation from the Joint Commission International (JCI).

In terms of technological advancements, the centre has introduced several innovative solutions. Adaptive radiotherapy leverages artificial intelligence (AI) and machine learning to adjust treatment plans in real-time based on daily anatomical changes. Radioembolisation, TARE-Y90 therapy offers a minimally invasive option for targeting liver cancer cells. Furthermore, High-Intensity Focused Ultrasound (HIFU) provides a non-surgical alternative for prostate cancer patients, emphasizing minimally invasive care.

The Fatima bint Mubarak Centre is not only focused on current treatments but also on the future of cancer care. It aims to lead in cancer research, education, and patient support while embracing technologies like generative AI, virtual reality and augmented reality, and predictive analytics. These tools are expected to enhance healthcare interventions' accuracy and effectiveness significantly.

As it moves into its second year, the centre continues to set benchmarks in cancer care by integrating advanced technologies with compassionate care. Its efforts are contributing significantly to the global fight against cancer, promising better outcomes and quality of life for patients.

With inputs from WAM